Evidence map›Paper›PMID 40826993›Full record

ArticleCancer medicine2025

RETRACTION: MicroRNA-320a Inhibits Invasion and Metastasis in Osteosarcoma by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 1.

Abstract readRetraction Notice
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionY. Wang, J. Yang, P. Chen, Y. Song, W. An, H. Zhang, B. Butegeleqi, and J. Yan, "MicroRNA-320a Inhibits Invasion and Metastasis in Osteosarcoma by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 1," Cancer Medicine 9, no. 8 (2020): 2833-2845, https://doi.org/10.1002/cam4.2919. The above article, published online on 17 February 2020 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Stephen Tait; and John Wiley & Sons Ltd. A third party reported that tumor images in Figures 2C and 6A had been duplicated from Figures 2C and 6A in a previously published article by different authors which involved different experimental conditions [Zou et al. 2016 (https://doi.org/10.18632/oncotarget.5689)]. The authors responded to an inquiry by the publisher and explained that the tumor images had been downloaded from the other article as a morphological reference and inadvertently were re-used during the figure preparation stage for their own article. The authors supplied what they described as the correct tumor images, but they did not supply all original data as requested by the publisher. Without all of the original data, the new images could not be validated. The retraction has been agreed to because the unattributed duplication of images from an earlier publication, which describes different experimental conditions, fundamentally compromises the editors' confidence in the results presented in this article. The authors did not respond to our notice regarding the retraction.

Identifiers

PMID40826993
PMCPMC12361629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.